- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · May 5, 2025 | 31.22M sh |
| Short Term Investments | Q2 2025 · Mar 31, 2025 | $10.54M |
| Short Term Investments | Q2 2025 · Sep 30, 2024 | $2.31M |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $152.07M |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $155.15M |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $162.47M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $164.33M |
| Current Assets | Q2 2025 · Mar 31, 2025 | $204.89M |
| Current Assets | Q2 2025 · Sep 30, 2024 | $199.24M |
| Total Assets | Q2 2025 · Mar 31, 2025 | $358.8M |
| Total Assets | Q2 2025 · Sep 30, 2024 | $346.89M |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 31.46M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 31.68M sh |
| Stock Repurchased | Q2 2025 · Mar 31, 2024 | $9.05M |
| Capex | Q2 2025 · Mar 31, 2024 | $4.11M |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | $25.97M |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $163.93M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $165.38M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $161.53M |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.18 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.24 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.19 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.25 |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $7.66M |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $15.24M |
| Net Income | Q2 2025 · Mar 31, 2024 | $5.71M |
| Net Income | Q2 2025 · Mar 31, 2024 | $7.62M |
| Net Income | Q2 2025 · Dec 31, 2023 | $1.91M |
| Operating Income | Q2 2025 · Mar 31, 2024 | $6.6M |
| Operating Income | Q2 2025 · Mar 31, 2024 | $8.24M |
| Gross Profit | Q2 2025 · Mar 31, 2024 | $47.23M |
| Gross Profit | Q2 2025 · Mar 31, 2024 | $87.03M |
| Revenue | Q2 2025 · Mar 31, 2024 | $91.45M |
| Revenue | Q2 2025 · Mar 31, 2024 | $162.78M |